Download the HawkPartners Brand Authenticity Index™ to create genuine connections with your consumers.

Close Notification Bar

Cynthia Herr

Send Cynthia Herr a Message

  • This field is for validation purposes and should be left unchanged.

Cynthia Herr helps clients develop effective marketing and brand strategies, assisting them with their most challenging strategic issues. She relies on primary and secondary research to better understand the market and the customer and takes a consultative approach to help clients make valuable decisions.

Cynthia’s work spans the pharmaceutical, professional services, consumer, financial and legal services industries, both domestically and internationally. Her experience includes years of qualitative and quantitative research with a wide range of audiences. She is well-versed in novel research techniques as well. She focuses most on new product development tactics, launch strategies, product positioning, market assessments and optimizing communications.

Prior to joining HawkPartners at its inception, Cynthia worked at the Middlesex County District Attorney’s office and prior to that, she lived in Italy working at the American School of Milan.

Cynthia is often found out running or swimming – if not, she might be in her backyard using her best marketing skills to try to convince her black lab puppy not to jump the fence. She insists she plays a mean game of Rummy 500, which may or may not be supported by fact-based research.

Cynthia received a BA with honors in Psychology from Williams College.

Perspectives by Cynthia Herr

The Jury of Now

An effective COVID trial strategy cannot be designed without first understanding the new COVID jury.  By instead conducting focused research, trial communications can be optimized to resonate among the jury of now.

What does COVID mean for the jury trial?

The COVID era trial must balance protecting the constitutional elements of a jury trial while protecting the nation’s health in a pandemic.  Both a socially distanced in-person approach and a virtual approach allow for that – but also pose challenges that trial teams have never encountered.